1 challenge in vaccine advancement is economic: Most of the diseases most demanding a vaccine, including HIV, malaria and tuberculosis, exist principally in poor international locations. Pharmaceutical companies and biotechnology businesses have small incentive to acquire vaccines for these conditions simply because You can find minimal earnings op